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MT1-MMP-Deficient Mice Develop Dwarfism,
Osteopenia, Arthritis, and Connective Tissue
Disease due to Inadequate Collagen Turnover
that MMPs play an important role in mediating funda-
mental cellular programs that depend on stromal remod-
eling such as cell migration, angiogenesis, and wound
healing (Mignatti and Rifkin, 1996; Okada et al., 1997;
Nagase, 1998). In addition, MMPs may be important
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Mouse strains deficient in several individual MMPsSummary
(MMP-2, MMP-3, MMP-7, MMP-9, MMP-12) have been
developed. All of these showed little or no impairment ofMT1-MMP is a membrane-bound matrix metallopro-
development and reproduction. In each case, however,teinase (MT-MMP) capable of mediating pericellular
specific cellular functions were altered or impaired eitherproteolysis of extracellular matrix components. MT1-
spontaneously or following defined experimental chal-MMP is therefore thought to be an important molecular
lenge (Shipley et al., 1996; Itoh et al., 1997; Wilson ettool for cellular remodeling of the surrounding matrix.
al., 1997; Masson et al., 1998; Mudgett et al., 1998; Vu etTo establish the biological role of this membrane pro-
al., 1998). To address by similar means the physiologicalteinase we generated MT1-MMP-deficient mice by
role of MT1-MMP, we generated mutant mice deficientgene targeting. MT1-MMP deficiency causes craniofa-
in MT1-MMP activity. We demonstrate here that MT1-cial dysmorphism, arthritis, osteopenia, dwarfism, and
MMP deficiency gives rise to a set of severe, generalizedfibrosis of soft tissues due to ablation of a collageno-
connective tissue abnormalities by impairing an essen-lytic activity that is essential for modeling of skeletal
tial collagenolytic activity.and extraskeletal connective tissues. Our findings
demonstrate the pivotal function of MT1-MMP in con-
Resultsnective tissue metabolism, and illustrate that modeling
of the soft connective tissue matrix by resident cells
Generation of MT1-MMP-Deficient Miceis essential for the development and maintenance of
To disrupt expression of the MT1-MMP gene, a 3.35 kbthe hard tissues of the skeleton.
segment containing sequences from the 39 half of intron
1 through the 39 end of exon 5 was replaced with a PGKIntroduction
controlled HPRT minigene (van der Lugt et al., 1991)
(Figure 1A). This deletion removed from the mature MT1-Matrix metalloproteinases (MMPs) constitute a family of
MMP protein amino acid residues 6±274 including allzinc endopeptidases that are capable of degrading most
but five residues of the prodomain and eight residuesof the structural components of the extracellular matrix
of the catalytic domain, rendering any polypeptide ex-(Birkedal-Hansen et al., 1993; Birkedal-Hansen, 1995;
pressed from this mutant gene catalytically inactive. TheWerb, 1997). The wide substrate specificity suggests
targeting vector was transfected into (HM-1) HPRT-defi-
cient mouse embryonic stem cells (Magin et al., 1992)
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7 These authors contributed equally. two individual cell clones were mated to Swiss Black
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Figure 1. Targeting of MT1-MMP
(A) Strategy for targeting of MT1-MMP. The
structure of the mouse MT1-MMP endoge-
nous gene, the MT1-MMP transgene tar-
geting vector, the targeted MT1-MMP gene
and the corresponding protein products are
depicted as diagrams. In the gene diagram,
intron sequences are depicted as open and
exon sequences as black boxes. Important
restriction sites are indicated. Restriction
sites in parenthesis are mutated and not
cleavable. The selective markers HPRT and
HSV-tk are depicted as shaded boxes. The
position of primers used for detection of the
targeted allele are indicated with A and B.
Probes used for hybridization are indicated
as P59 and P39. Protein diagram abbrevia-
tions are as follows: PRO, prodomain; CAT,
catalytic domain; HIN, hinge region; PEX,
hemopexin domain; TM, transmembrane do-
main. ªDeleted regionº indicates the part of
the MT1-MMP protein that is removed by the
homologous recombination event.
(B) Identification of transgenic animals by
Southern blot: 1/1, wild-type; 1/2, hetero-
zygous; 2/2, homozygous mutant. HindIII-
restricted samples were size fractionated and
hybridized to the P39 probe. HindIII/BglII-
restricted samples were size fractionated and
hybridized to the P59 probe. The fragment
size of the analytical restriction digest is indi-
cated in base pair length and with double
arrowhead lines in (A).
(C) Detection of MT1-MMP mRNA in total ne-
onate RNA by Northern blot. The genotypes
are abbreviated as described for Southern
blot. Probes used for detection of fraction-
ated RNA are indicated (P59 and P39).
(D) Dorsal view of 10-day-old MT12/2 mouse
and control littermate (MT11/2).
(E) Close-up of 79-day-old MT12/2 mouse.
mice and germline transmission of the targeted allele and after day 50 experienced progressive wasting,
patchy hair loss, reduced mobility, kinking of the wrist,was obtained with chimeras derived from both clones
(Figure 1B). Interbreeding of heterozygous mice gave and hyperlordosis/hyperkyphosis (Figures 1D and 1E).
The mutant mice showed no signs of sexual maturation,rise to the expected Mendelian distribution of homozy-
gous mutant mice (MT12/2), heterozygous (MT11/2) mice, and most of the animals died between days 50 and 90.
In most, if not all cases, death occurred due to wasting.and wild-type (MT11/1) mice. RNA prepared from total
neonatal MT12/2 tissues and probed with exon 1± or Heterozygous mice appeared indistinguishable from
wild-type littermates. Thus, deleterious effects of anyexon 6±9±specific probes showed no transcripts of the
size or intensity characteristic of MT1-MMP mRNA from protein translated from the low levels of aberrant size
message detected by Northern blot did not account forwild-type or heterozygous littermates (Figure 1C).
the observed phenotype in MT12/2 animals.
MT1-MMP-Deficient Mice Are Viable but Display
Severe Runting, Wasting, and Increased Mortality MT1-MMP Deficiency Causes Skeletal Dysplasia,
Arthritis, Severe Osteopenia, and GeneralizedNeonate MT1-MMP-deficient mice could not be distin-
guished visibly from heterozygous and wild-type lit- Soft Tissue Disorders
MT1-MMP deficient mice gradually developed a severetermates at birth although subsequent X-ray analyses
showed evidence of aberrant cranial bone formation skeletal phenotype (Figures 1D, 1E, and 2). Short snout,
orbital protrusions, hypertelorism, and dome-shapedalready at birth. Hair growth and eye opening occurred
without retardation, but growth impairment (smaller skull with bulging parietal and interparietal regions be-
came obvious at day 5 (Figures 1D and 1E). Membranousbody size and weight) became evident as early as 5
days. In cohorts of 30 mice weaning weight for MT12/2 ossification of calvarial bones was delayed and suture
closure was never completed (Figures 2A and 2C). Be-animals ranged from only 3.5 to 5 g versus 12 to 16 g
for wild-type or heterozygous mice, and 33% of mutant ginning at day 5, the limb bones appeared shorter than
in control littermates and grew to approximately 65%animals died from wasting before weaning. Surviving
mutant mice gained little weight over the next few weeks of the length of controls by day 45 (Figures 2B and
Connective Tissue Disease in MT1-MMP2/2 Mice
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Figure 2. Bone Development in MT1-MMP-
Deficient Mice
(A) Alizarin red/alcian blue staining of skulls of
MT1-MMP-deficient (2/2) and control (1/1)
mice demonstrating larger fontanelles and
gradually increasing cranial dysmorphism of
mutant mice (33 magnification).
(B±D) Lateral X-ray images of 80-day-old
MT1-MMP-deficient (B) and wild-type lit-
termate (D), (0.753 magnification). (C) 33
magnification of cranial vault from the animal
in (B). Note the wide sutures and the displace-
ment of the interparietal bone (arrowheads).
(E and F) X-ray images of hind limb bones
from 80-day-old MT1-MMP-deficient (F) (33
magnification) and wild-type littermate (E)
(23 magnification). Note the severe osteope-
nia of the mutant mouse.
(G±J) Histology of the femora of 60-day-old
MT1-MMP-deficient (G and I) and wild-type
(H and J) mice. Note the severe reduction
of trabecular bone in the spongiosa and the
thinner cortex in the mutant animal (G±H).
Goldner's stain. Bars 5 150 mm (G and H);
400 mm (I and J).
2D±2F). Osteopenia became increasingly apparent and by cartilage primordia (Kaufmann, 1998). We identified
a distinct anomaly in postnatal development of thesebone mass was severely reduced in animals aged 40
days or older (Figures 2G±2J). Concurrently, MT1-MMP- primordia in MT1-MMP-deficient mice, which also
helped to more clearly define the normal process gov-deficient mice developed severe generalized arthritis
(Figures 3A±3F). All joints showed overgrowth of a hy- erning ossification. To our knowledge, this process has
not previously been fully described. The postnatal devel-percellular, vascularized synovial tissue and destruction
of articular cartilage, resulting in ankylosis (Figure 3E). opment of the most conspicuous primordium, the pari-
etal cartilage (Chen et al., 1998)Ðwhich is located inTRAP-positive, osteoclast-like giant cells were promi-
nent within articular and periarticular soft tissues (Fig- the region where parietal and interparietal bones later
developÐis shown in Figure 4. Toward the base of theures 3C and 3D). Tendons, ligaments, synovial capsules,
musculotendinal junctions, and septal/fascial structures cranium, the parietal cartilage merged with the cartilage
precursor of the pars petrosa of the temporal bone. Inassociated with skeletal muscle all displayed increased
cell proliferation and vascularity, and became increas- normal mice, the cartilaginous precursor of the pars
petrosa, and the parietal cartilage (both clearly detect-ingly fibrotic. Older animals developed progressive fi-
brosis of the dermis and of hair follicles, which coincided able in newborn mice) were completely replaced by
bone at day 15 (Figures 4A±4D). Upon completion of thewith hair loss.
process, the osseous pars petrosa and the osseous
interparietal/parietal bones were joined by typical su-Abnormal Cranial Morphogenesis in MT1-MMP2/2
Mice: Impaired Removal of Calvarial Cartilage tures. The pars petrosa ossified endochondrally whereas
the parietal and interparietal bones ossified intramem-Primordia Interferes with Membranous Bone
Formation and Suture Closure branously over the outer aspect of the parietal cartilage.
Endochondral ossification of the cartilage precursor ofMembranous ossification of the parietal, orbital, and
lower frontal regions of the mouse calvarium, which are the pars petrosa occurred in timely fashion in both nor-
mal and mutant mice but the parietal cartilage was neverdysmorphic in MT1-MMP-deficient mice, is preceded
Cell
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Figure 3. Arthritis in MT1-MMP-Deficient Mice
Metatarsal±phalangeal joint of 40-day-old
MT1-MMP-deficient mouse (A), and normal
littermate (B). Note the prominent synovitis
and the overgrowth of inflamed synovial tis-
sue over the articular cartilage (arrows) in (A).
(C and D) Osteoclast-like cells in articular soft
tissues of MT1-MMP-deficient mice. (C)
TRAP-positive cells at the lateral aspect of a
fibrocartilage meniscus in the knee joint. (D)
Large numbers of TRAP-positive cells in the
synovial overgrowth covering the articular
surface of the condyle. (E) Severe ankylosis
due to extensive fibrosis of the articular soft
tisues in the knee joint of a 103-day-old MT1-
MMP-deficient mouse. (F) Control littermate.
Asterisks indicate the fibrotic tissue in the
mutant mouse and the normal synovial adi-
pose cushion in the wild type. Bars 5 200 mm
(A and B); 150 mm (C and D); 800 mm (E and F).
removed in MT1-MMP-deficient mice. This primordium mice eventually did ossify, in the absence of vascular
canals, but by an alternative mechanism. The endochon-persisted but was gradually transformed into an increas-
dral ossification proceeded directly from the perichon-ingly fibrotic and acellular vestige on the inner aspect
drium behind osteoclastic resorption of the calcifiedof the underdeveloped parietal/interparietal bone at
cartilage matrix, but only after full expansion of the regionleast up to 60 days of age (Figures 4E±4H). The re-
of cartilage mineralization to the very periphery of thegressing parietal cartilage in normal animals never
epiphyses (Figures 5I±5J). Following this delayed develop-calcified but gradually dissolved and disappeared by a
ment of secondary epiphyseal centers, the metaphysealprocess that did not involve osteoclasts. We interpret
growth plates of mutant mice underwent progressivethe persistence of the parietal cartilage vestige in MT1-
thinning and disorganization (Figures 2G and 2H). BrdUMMP-deficient mice to indicate that a collagenolytic
labeling revealed that chondrocyte proliferation wasmechanism responsible for dissolution of this cartilage
markedly reduced in growth plates of 39-day-old MT1-matrix was impaired. This specific chondrolytic process
MMP-deficient mice (Figures 5K and 5L) whereas nois MT1-MMP-dependent and indispensable for timely
such difference was observed at 10 days (not shown).removal of cartilage primordia as they are replaced by
bone formed by intramembranous ossification.
Increased Osteoclastic Resorption and Decreased
Bone Formation are Associated With Progressive
Endochondral Ossification in MT1-MMP2/2 Mice: Fibrosis of Periskeletal Soft Tissues and Arthritis
Deficient Vascularization of Hyaline Cartilage The progressive osteopenia observed in adult MT1-
Disrupts Secondary Ossification and Growth MMP-deficient mice was a result of increased bone re-
Plate Development sorption as well as diminished bone formation. Exces-
Maturation, hypertrophy, and calcification of pre- and sive osteoclastic resorption was observed in all bones
early postnatal metaphyseal growth plates were essen- of mutant mice aged 40 days or older (Figures 6A±6C).
tially normal in mutant mice. In contrast, the postnatal The largest number of osteoclasts was found near bone/
development of the epiphyseal (secondary) ossification soft tissue interfaces: at the bony edges of the open
centers was markedly delayed. Vascular canals, which fibrotic cranial sutures, within and near arthritic joints
normally penetrate the uncalcified hyaline epiphyseal and near tendon, ligament, and capsule insertions of
cartilage, did not form. Vascular invasion and subse- long bones. Dual calcein labeling revealed that bone
quent endochondral ossification of the epiphyseal cen- formation was dramatically reduced in MT1-MMPdeficient
ters normally proceeds from these canals (Figures 5A± mice (Figures 6D and 6E). The periosteal osteogenic
5H), and their absence in mutant animals severely layer of long bones showed marked fibrosis, reduced
retarded secondary ossification. After a delay of about cell proliferation (data not shown), and structural disor-
ganization in mice aged 40 days or older (Figures 6F±6I).8 days, the epiphyseal centers of MT1-MMP-deficient
Connective Tissue Disease in MT1-MMP2/2 Mice
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Figure 4. Impaired Chondrolytic Regression
of Calvarial Cartilage Primordia in MT1-MMP-
Deficient Mice
Coronal sections through the interparietal
bones of newborn, 10-, 15-, and 60-day-old
normal (A±D) and mutant (E±H) littermates. In
newborn mice, the interparietal (and parietal)
bones grow on the outside of a cartilage pri-
mordium in continuity with the pars petrosa
of the temporal bone (A±D). Cartilage hyper-
trophy is obvious in the pars petrosa at day
10, both in normal and mutant mice (asterisks
in B and F). Above the region of cartilage
hypertrophy, the parietal cartilage primor-
dium disappears in normal mice, leaving
room for the advancing front of membranous
ossification ([B], double arrows, and details
in [I] and [J]). In mutant mice, a fibrous vestige
of the cartilage primordium ([F], double
arrows and details in [K], and [L]) contiguous
with the hypertrophic cartilage of the pars
petrosa ([F], asterisk; [K], thick arrow) re-
mains. At day 15 in normal mice (C), both the
pars petrosa (C, asterisk) and the interparietal
bone are fully ossified, and joined by a typical
suture (C, thick arrow). At day 15 in mutant
mice (G) endochondral ossification of the
pars petrosa has been completed (G, aster-
isk), but membranous ossification of the inter-
parietal bone is incomplete, and the vestige
of the cartilage primordium persists at its in-
ner aspect (G, double arrow). The lower end
of this primordium interferes with suture for-
mation (G, thick arrow). At 60 days, the suture
has become highly fibrotic in mutant mice (H,
thick arrow) and an acellular fibrous vestige
of the primordial cartilage is still detectable
(H, double arrows). (I±L) Sections from 10-
day-old mice stained with Masson's tri-
chrome (I and K) and alcian blue (J and L). (I
and J) normal mice, (K and L) mutant lit-
termates. Thick arrows indicate the unre-
moved parietal cartilage vestige, which has
lost alcianophilia for the most part (L). Thin
arrows indicate the forming interparietal
bone. The dashed line marks the site of the
developing suture, and the boundary be-
tween the pars petrosa and the parietal carti-
lage. Bars 5 150 mm (A±H); 70 mm (I±L).
Osteoblasts located at or near bone surfaces were dis- mice demonstrated that the expression level of type I
and type II collagen was equivalent in all animals (dataplaced into the dense fibrotic periosteal matrix and
frequently showed abundant coarse cytoplasmic inclu- not shown). We therefore concluded that excess colla-
gen deposition was unlikely to be caused by increasedsions containing collagen fibrils (Figures 6J±6L). North-
ern blot analysis of total RNA from wild type and mutant expression.
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Figure 5. Abnormal Long Bone Development
in MT1-MMP-Deficient Mice
(A and B) Femur, 5-day-old mutant and nor-
mal mice. Formation of epiphyseal vascular
canals within uncalcified epiphyseal cartilage
is absent in the mutant mouse (A) and present
in the normal littermate (B, arrow and inset).
(C and D) Femur, 10-day-old mutant and nor-
mal mice. Obvious features of epiphyseal car-
tilage hypertrophy in the mutant mouse (C).
Note the complete absence of vascular ca-
nals and of ossification. Ossification of sec-
ondary (epiphyseal) center has started in the
normal mouse (D). Invasion of the epiphyseal
ossification center proceeds from vascular
canals (D, boxed, E and F) which penetrate
the uncalcified cartilage of the epiphyseal
condyle. (G and H) Proximal epiphyses of the
tibia of mutant (G) and normal (H) mice, day
16. Ossification of the epiphysis is extensive
in the normal mouse, but only beginning in
the mutant. (I and J) Femoral epiphysis of 16-
day-old mutant mouse. Invasion of the carti-
lage is led by calcified-cartilage resorbing
osteoclasts (I; arrows, J). Osteoclastic re-
sorption of the now mineralized cartilage pro-
ceeds without prior development of vascular
canals. (K and L) BrdU labeling of the tibial
growth plates from 39-day-old mice showing
markedly reduced labeling in the mutant (K).
Compare to the normal littermate (L). Bars 5
300 mm (A±D); 120 mm (E and F); 200 mm (G±I);
70 mm (J); 180 mm (K and L).
MT1-MMP Deficiency Impairs Collagenolytic Activity osteogenic cells were loaded onto either (denatured)
insoluble collagen-type-I-based (Gelfoam) or hydroxy-and Osteogenic Potential of Osteoblasts
Since our findings showed that bone formation was apatite-based carriers and transplanted into the subcu-
tis of immunocompromised, but MT1-MMP-sufficientmarkedly reduced in MT1-MMP deficient animals, we
asked whether MT1-MMP deficiency caused an intrinsic mice. With both carriers, cells from control mice formed
complete ectopic ossicles composed of abundant bonedysfunction of osteogenic cells, rather than systemic
(e.g., hormonal, nutritional) imbalances, or dysfunction and hematopoietic marrow (Figure 7A). In contrast, cells
from mutant littermates formed only scant amounts ofof other skeletal cell types or tissues (for instance vascu-
lature). To answer this question, we isolated clonogenic bone indicating that the osteogenic activity of marrow-
derived osteogenic cells from these animals was se-osteoprogenitor cells (CFU-F) from the bone marrow of
mutant mice and normal littermates, and probed their verely deficient (Figure 7A). The Gelfoam matrix was
efficiently degraded and replaced by bone and marrowability to form bone in a transplantation assay (Krebs-
bach et al., 1997). Cells from mutant mice showed higher in ossicles formed by MT1-MMP-sufficient cells, whereas
a significant fraction of the collagenous carrier materialcolony forming efficiency than cells from normal lit-
termates (data not shown), indicating that CFU-F were remained undegraded in ossicles formed by mutant cells
(Figure 7A). We concluded that MT1-MMP-deficientnot quantitatively deficient in the bone marrow of mutant
mice. Culture-expanded populations of marrow-derived marrow stromal cells possess two seemingly related
Connective Tissue Disease in MT1-MMP2/2 Mice
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Figure 6. Bone Resorption and Formation in
MT1-MMP-Deficient Mice
(A) TRAP staining of whole calvaria of 68-
day-old mutant (2/2) and normal (1/1)
littermates. The TRAP staining results in
ªpaintingº of the patent sutures in the mutant
(arrowheads), indicating osteoclastic activity.
(B and C) TRAP staining of the femoral cortex
(metaphysis) in 68-day-old mutant (B) and
wild-type (C) littermates (Nomarski optics).
Note the large excess of osteoclasts in (B).
(D and E) Calcein labeling of 69-day-old mice,
tibial metaphysis. Mutant animals display a
dramatic reduction in bone forming activity
(D) compared to the wild-type littermate (E).
(F±I) Sections of femur of 51-day-old normal
mouse (F and H) and mutant littermate (G and
I), stained with H&E (F and G), and reacted
for ALP (H and I) to demonstrate osteogenic
cells (arrows). In the mutant, the cortical bone
is markedly reduced in thickness and is lined
by a thick fibrotic layer. ALP-positive cells are
dispersed across the fibrotic layer (I, arrows).
(J±L) Osteoblasts of the fibrotic perisoteum
of older animals contain intracellular collagen
fibrils. (J), Trichrome strain. (K), ALP activity
and (L), EM. Bars 5 2.1 mm (A); 180 mm (B±E);
200 mm (F±I); 10 mm (J and K); 1.5 mm (L).
defects: impairment of osteogenic capacity and impair- with TNFa/IL-1b. Cells from MT1-MMP-deficient lit-
termates, however, completely failed to degrade thement of collagenolytic/gelatinolytic activity.
collagen matrix demonstrating that MT1-MMP defi-
ciency imparts a severe defect in collagenolytic activityMT1-MMP-Deficient Skin Fibroblasts Are Incapable
of Degrading Type I Collagen Matrices In Vitro and that degradation of type I collagen fibrils in this
system is absolutely dependent on MT1-MMP (Figure 7B).Because of the apparent inability of MT1-MMP-deficient
marrow stromal cells to degrade the collagenous Gel-
foam matrix, we sought to verify that MT1-MMP-defi-
cient cells were deficient in collagenolytic activity. Skin Discussion
fibroblasts isolated from newborn mice were seeded in
a pellet on a reconstituted type I collagen fibril film and Targeted disruption of the MT1-MMP gene in mice re-
sults in a series of severe connective tissue growth andincubated in serum-free medium. Cells derived from
wild-type or heterozygous mice readily degraded the remodeling disorders including dwarfism, osteopenia,
fibrosis of soft tissues, arthritis, and skeletal dysplasia.underlying collagen film particularly when stimulated
Cell
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Figure 7. Osteogenesis and Collagen Break-
down by MT1-MMP-Deficient and Wild-Type
Cells
(A) Function of osteogenic progenitor cells
evaluated by their ability to form ectopic ossi-
cles following transplantation in a collagen-
based carrier in SCID mice. (a) Low-power
view of the ossicle formed by cells derived
from control animals. Note the well-devel-
oped bone cortex and marrow cavity with tra-
becular bone. (c) Low-power magnification of
an ossicle formed by cells derived from MT1-
MMP-deficient mice. Note the absence of
cortical bone and little evidence of a marrow
cavity. (b) High power view of the ossicle in
(a) showing hematopoiesis, trabecular bone
and adipocytes. (d) High power view of the
ossicle in (c). Note the large amount of unde-
graded carrier. Bars 5 0.8 mm (a and c); 250
mm (b and d).
(B) Collagenolytic activity of newborn skin fi-
broblasts seeded on a reconstituted type I
collagen film. Note the failure of MT1-MMP-
deficient to degrade the collagen film.
Inability to degrade and remodel unmineralized collage- severely impaired to the extent that coordinated growth
of the bone/soft tissue unit was compromised. As thenous matrices at sites that normally express MT1-MMP
in the developing mouse emerges as a common denomi- soft tissues failed to remodel, the bone surface at the
soft tissue insertion sites became a target for excessivenator for these abnormalities. Consistent with these ob-
servations, cells derived from MT1-MMP-deficient ani- osteoclastic bone resorption. Since bone is the only
structure that can be efficiently remodeled in mutantmals have lost an indispensable collagenolytic activity
against type I/II collagen-rich matrices. Our findings thus animals, we propose that increased bone resorption vis-
aÁ -vis the development of soft tissue fibrosis constitutesillustrate the pivotal and indispensable role of this colla-
genolytic activity in stromal remodeling and in the devel- a partially successful compensatory response enabling
continued growth.opment, growth, and maintenance of connective tissue
structures throughout the body.
Impaired Remodeling of Periskeletal Soft Tissues MT1-MMP Is Essential for Growth Plate Function
and Secondary OssificationGives Rise to Compensatory Osteoclastic
Bone Resorption to Accommodate Growth Endochondral bone formation at metaphyseal growth
plates involves coordinated removal of calcified carti-The skeleton is a major target for adverse effects of MT1-
MMP deficiency (reduced longitudinal growth, cranial lage by osteoclasts and subsequent replacement by
bone deposited by osteoblasts. This process is essen-dysmorphism, osteoclasia, and osteopenia). None of
these effects, however, reflect any detectable impair- tially normal in MT1-MMP-deficient mice throughout
prenatal development and even for some time after birth.ment of the osteoclast-mediated degradation of bone
or calcified cartilage matrix. Rather, bone resorption and We therefore conclude that the complex developmental
program required for proper growth plate functionosteoclastic activity are greatly increased in MT1-MMP-
deficient mice. This is in agreement with the notion that (chondrocyte differentiation, maturation, hypertrophy,
cartilage calcification, osteoclastic erosion), per se, isthe collagenous-matrix-degrading activity of osteo-
clasts primarily is dependent on acidic proteinases of not dependent on MT1-MMP activity. The development
of epiphyseal (secondary) centers of ossification, how-the cathepsin family (Garnero et al., 1998; Saftig et al.,
1998), thus questioning MT1-MMP activity as essential ever, is disrupted in MT1-MMP-deficient mice. Invasion
of the uncalcified epiphyseal hyaline cartilage by vascu-for bone resorption. The progressive fibrosis of liga-
ment, tendon and capsular insertions in bone suggests lar canals which represents a critical early step in the
development of the secondary centers of ossificationthat timely remodeling of these soft tissue matrices was
Connective Tissue Disease in MT1-MMP2/2 Mice
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(Lutfi, 1970; Kuettner and Pauli, 1983; Cole and Weze- bones, parietal and interparietal bones) develop by
membranous ossification but are preceded by conspic-man, 1985) failed to occur. It is noteworthy that such
vascular canals have previously been shown to express uous cartilage primordia (Kaufmann, 1998). Taken to-
gether, these findings suggest that development andMT1-MMP (StaÊ hle-BaÈ ckdahl et al., 1997). The formation
of vascular canals involves degradation of uncalcified timely removal of cartilage primordia are critical steps
in cranial morphogenesis and suture formation. It is alsocartilage to clear a path for invading vessels that bring
in osteogenic precursor cells for the ensuing ossification interesting to note that facial features similar to those
of the MT1-MMP-deficient mouse have been reportedprocess. MT1-MMP plays a critical role in this angio-
genic process although angiogenesis in general is not previously in a mouse mutation, pn (Kidwell et al., 1961),
with the same chromosomal location as mt1-mmp (Apteimpaired in mutant mice. The failure to form vascular
canals coincided with the onset of diminished longitudi- et al., 1997). Unfortunately, this mouse strain is no longer
available.nal growth of long bones. The growth plates soon after
showed progressive abnormalities including thinning,
disorganization, and lack of chondrocyte proliferation. Remodeling of Unmineralized Connective Tissue
Considering their normal appearance prior to this time, Is Essential for Bone Formation
we speculate that the delay of epiphyseal ossification We have demonstrated that the function of bone-form-
may impair growth plate function. It has previously been ing cells is severely impaired by MT1-MMP deficiency.
suggested that mesenchymal cells which reach the inte- This defect is coincident with signs of severe disorgani-
rior of the epiphyseal cartilage by association with the zation and disruption in the osteogenic periosteum.
blood vessels in vascular canals also serve as a reservoir Transplantation of osteogenic cells to MT1-MMP-suffi-
of precursor cells for epiphyseal cartilage growth (Lutfi, cient hosts confirmed that MT1-MMP deficiency caused
1970). If that is indeed the case, it is likely that the delay an intrinsic defect of osteogenic cells that could not be
of epiphyseal vascularization results in a shortage of rescued by an MT1-MMP-sufficient environment. The
chondrocyte precursors and subsequent growth plate transplantation experiment also showed that the defect
atrophy, as observed in MT1-MMP null mice. in osteogenesis is coupled to inability to degrade a col-
lagenous matrix, a finding that is consistent with exten-
sive fibrosis of the osteogenic periosteum and disrup-MT1-MMP Deficiency Demonstrates the Fate and
tion of its highly ordered cellular architecture. TheFunction of Cartilage Primordia in Cranial
unusual finding of collagen fibrils inside osteoblasts,Membranous Ossification
moreover, suggested that these cells attempted to mo-The craniofacial dysmorphology of MT1-MMP-deficient
bilize a compensatory phagocytic pathway of collagenmice is particularly intriguing because it provides new
degradation (Melcher and Chan, 1981). We thereforeinsights into normal craniofacial development. The cra-
speculate that inability to remodel the surrounding col-niofacial abnormalities appear to be primarily associ-
lagenous matrix may result in disorganization of theated with formation of membranous cranial bones and
osteoblast layer, displacement of osteoblasts, and fail-removal of their cartilage primordia. The role of these
ure to achieve a level of coordinated function requiredprimordia is currently unclear, but they represent a
for bone formation.prominent feature of embryonic cranial development in
the mouse that has repeatedly been noted, but never
fully explained (Ducy et al., 1997; Otto et al., 1997; Chen MT1-MMP Deficiency Gives Rise to Arthritis
The development of severe arthritis in aging MT1-MMP-et al., 1998; Kaufmann, 1998). Membranous ossification
of the parietal/interparietal bones proceeds through deficient mice is particularly noteworthy in view of the
many reports in the literature of overexpression of indi-synchronous progression of bone formation and re-
moval of the parietal cartilage so that the narrow over- vidual MMPs in human arthritis (StaÊ hle-BaÈ ckdahl et al.,
1997; Johnson et al., 1998). This observation should belapping boundary between the two moves gradually and
continuously from the top toward the base of the skull. carefully considered before employing MMP inhibitors
in arthritis therapy. The arthritis that develops in MT1-The developing bone forms outside the cartilage primor-
dium and not within it as is the case in endochondral MMP-deficient mice bears some resemblance to both
murine collagen-induced arthritis and human rheuma-ossification. Our findings have shown that these carti-
lage primordia do not calcify and are not removed by toid arthritis; one noted element of similarity being the
development of TRAP-positive osteoclast-like cells inosteoclasts, but rather by an entirely different directional
chondrolytic process that is highly coordinated with the articular and periarticular soft tissues (Gravallese et al.,
1998; Suzuki et al., 1998). Although our experimentsprogression of bone formation. This chondrolytic pro-
cess is specifically impaired in MT1-MMP-deficient have not addressed the pathogenesis of arthritis in MT1-
MMP-deficient mice, we note that interfaces betweenmice. Consequently, an uncalcified, fibrous remnant of
the calvarial cartilaginous primordium remains ªinsideº bone/cartilage and articular soft tissues are most se-
verely affected. These are also sites where MT1-MMPthe cranial bones far into adulthood. It is interesting to
note that underdevelopment of calvarial cartilage pri- is expressed at particularly high levels (Apte et al., 1997).
In the knee for example, the insertion of the cruciatemordia in the lmx1b mutant mouse is associated with
premature closure of cranial sutures (Chen et al., 1998), ligament where ligament, bone, and articular cartilage
interface was most profoundly affected. These observa-whereas in MT1-MMP-deficient mice failure to remove
the cartilage primordia results in permanently open su- tions raise the question whether the arthritic changes
in MT1-MMP-deficient mice develop as a result of inap-tures. We note that all dysmorphic cranial bones in the
MT1-MMP-deficient mice (orbital portions of frontal propriate remodeling during growth.
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HAT-resistant clones were expanded and screened for the legiti-MT1-MMP Mediates Pericellular Collagenolysis
mate targeting event using a primer complementary to the HPRTand Is Indispensable for Development
minigene p01: 59 GTG CGA GGC CAG AGG CCA CTT GTG TAG CGand Growth
39; and a primer complementary to sequences not included in the
Our findings have shown that MT1-MMP is indispens- targeting vector p02: 59 GAA GAA GTA GGT CTT CCC ATT GGG
able for growth and development and that lack of this CAT 39. Cell clones containing the targeted allele were further char-
acterized by Southern blot analysis. For analysis of the 39 end ofenzyme cannot be adequately compensated by other
the targeted gene, DNA was restricted with HindIII, gel fractionated,membrane-associated MMPs, by other MMPs or by
and hybridized to a 495 bp PCR-generated cDNA probe spanningother collagen degrading mechanisms. MT1-MMP has
all of exons 6 through 8. For analysis of the 59 end of the targetedbeen implicated as a possible activator of MMP-2 and
gene, DNA was restricted with HindIII/BglII, gel fractionated, and
MMP-13 (Strongin et al., 1995; Cowell et al., 1998), and hybridized to an 80 bp SstII probe spanning exon 1.
MT1-MMP is sometimes, but not always coexpressed To generate chimeric mice, targeted ES cells were injected into
72 hr±old blastocysts from C57BL/6 mice and implanted into pseu-with either MMP-2 or MMP-13 in mice (Gack et al., 1995;
dopregnant B6D2 or C57BL/6 3 DBA females (NCI±Frederick, Fred-Mattot et al., 1995; Kinoh et al., 1996; Apte et al., 1997).
erick, MD). Offspring were mated to Black Swiss mice (Taconic,MMP-2-deficient mice, however, display a rather subtle
Germantown, NY) to generate heterozygous animals for the targetedphenotype that appears to have little, if anything, in
gene. These were subsequently interbred to generate homozygous
common with the MT1-MMP phenotype (Itoh et al., mutant progeny.
1997), thus all but dispelling the hypothesis that the Genotyping of animals was performed by PCR amplification of
DNA obtained from tail biopsies with primers p01: 59 GTG CGA GGCMT1-MMP-deficient phenotype is primarily caused by
CAG AGG CCA CTT GTG TAG CG 39 and p03: 59CTT TGT GGG TGAfailure to activate MMP-2. Moreover, MT1-MMP and
CCC TGA CTT GC 39 to detect the targeted allele; and primers p04:MMP-13 are not coexpressed in embryonic tissues such
59 CTA GGC CTG GAA CAT TCT AAC GAT C 39 and p03: 59CTT TGTas tendon, which later become profoundly affected in
GGG TGA CCC TGA CTT GC 39 to detect the wild-type allele.
MT1-MMP-deficient mice. We therefore surmise that the
effects of MT1-MMP deficiency, at least in the mouse, Preparation of RNA
may not exclusively be mediated by lack of activation Total RNA was prepared by snap freezing tissue in liquid N2 followed
by extraction in Trizol (GIBCO-BRL, Gaithersburg, MD). Twenty-of MMP-13. At the cellular level, however, MT1-MMP
microgram samples of total RNA were size fractionated on formalde-deficiency does lead to the loss of an indispensable
hyde agarose gels, immobilized on nylon membranes, and hybrid-collagenolytic activity. Based on these observations and
ized to the radiolabeled probes used for Southern blot analysis.on existing evidence that MT1-MMP is capable of cleav-
ing extracellular matrix substrates such as collagen and X-Ray Imaging
fibrin (Ohuchi et al., 1997; Hiraoka et al., 1998), we raise X-ray imaging of animals was performed in a Faxitron MX-20 X-ray
the question whether MT1-MMP functions as a collagen- machine (Faxitron X-ray Corp., Buffalo Grove, IL).
ase in its own right or through activation of known or
In Vivo Labelingyet unrecognized type I/type II collagen-degrading pro-
Calcein (25 mg/kg bodyweight in 2% NaHCO3) was injected i.p. atteinases. Regardless, loss of MT1-MMP-directed prote-
day 0 and 10 days later. Tissues were harvested at day 12 and fixedolysis results in profound and far reaching physiological
in 70% ethanol. Bones were processed for methyl-methacrylate
consequences. Equally significant, the phenotype illus- embedding and 10 mm sections were analyzed by fluorescence
trates the importance of collagenous stromal remodel- microscopy in a Zeiss Axiophot. BrdU labeling was performed as
ing for development and growth, and for maintenance described (Vu et al., 1998).
of the otherwise invisible functional continuity between
Histology and Microscopythe soft and hard tissue components of the skeleton.
Tissues were fixed in neutral buffered formalin, decalcified in formic
acid or EDTA, paraffin embedded, sectioned at 6 mm, and stained
Experimental Procedures with H&E, Masson's trichrome, PAS stain, or alcian blue. Additional
samples of long bones were fixed embedded undecalcified in glycol-
All procedures were performed in accordance with an institutionally methacrylate (GMA) at low temperature or in methyl-methacrylate
approved protocol for the use of animals in research. (MMA). Two-to-four mm±thick GMA sections were reacted for TRAP
or ALP activity as described (Bianco et al., 1984). MMA sections
were stained with Goldner's or von Kossa's stains. Entire calvariaConstruction of Targeting Vector and Generation
were fixed in 70% ethanol for 5 min and reacted for TRAP and ALPof Transgenic Mice
using Sigma (St. Louis, MO) kits. Alcian blue/alizarin red stain wasThe MT1-MMP replacement type targeting vector was constructed
performed as described (Kaufmann, 1998). For EM, mice were perfu-using gene sequences cloned from a 129 strain mouse genomic
sion fixed with 2% paraformaldehyde/2% glutaraldehyde in 0.1 Mlibrary in the Lambda Fix II vector (Stratagene, La Jolla, CA). The
cacodylate buffer, pH 7.4. Samples were decalcified in 0.1 M EDTAtargeting vector cloned into pBluescript SK1 included a 4.9 kb 59
in 0.15 M phosphate buffer, postfixed in 1% OsO4, and embeddedhomology spanning sequences from BglII site in the proximal pro-
in Spurr's medium. Thin sections were photographed in a JEOL 100moter to the XbaI site in the middle part of intron 1. The 1.3 kb 39
CXII electron microscope.homology encompassed sequences from the PvuI site in exon 5 to
the KpnI site in exon 8. Sequences from the XbaI site in intron 1
through the PvuI site in exon 5 were replaced with a phosphoglycer- In Vivo Assay of Osteogenic Capacity of Bone
Marrow±Derived Stromal Cells from Normalate kinase promoter±driven HPRT minigene EcoRI cassette (van der
Lugt et al., 1991). The targeting vector was completed by addition and Transgenic Mice
Osteogenic precursor cells (bone marrow stromal cells) were de-of an HSV-tk minigene cloned into the KpnI site in the 39 terminus
of the short homology and the KpnI site of the plasmid polylinker. rived from the bone marrow of 2-month-old mice as described (Kuz-
netsov and Gehron Robey, 1996). Confluent cultures were passagedHM-1 mouse ES cells (Magin et al., 1992) were transfected with
the targeting vector and subjected to selection in growth medium 3 times, and 2.4 3 106 BMCSs were mixed with denatured type I
collagen sponges (25±50 mm2, Gelfoam, Upjohn, Kalamazoo, MI) orsupplemented with 0.1 mM hypoxanthine, 16 mM thymidine, 0.4 mM
aminopterin (HAT supplement, GIBCO-BRL, Gaithersburg, MD), and hydroxyapatite-tricalcium phosphate ceramic particles (40 mg of
particles, Zimmer, Warsaw, IN) and transplanted to the subcutis2 mM ganciclovir (Roche Laboratories, Nutley, NJ).
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of immunocompromised (NIH-bg-nu-xidBR) mice (Harlan Sprague Garnero, P., Borel, O., Byrjalsen, I., Ferreras, M., Drake, F.H., McQue-
ney, M.S., Foged, N.T., Delmas, P.D., and Delaisse, J.M. (1998). TheDawley, Indianapolis, IN). Ossicles were harvested for histology at
collagenolytic activity of cathepsin K is unique among mammalian8 weeks as described (Krebsbach et al., 1997).
proteinases. J. Biol. Chem. 273, 32347±32352.
Collagen Degradation Assay Gravallese, E.M., Harada, Y., Wang, J.T., Gorn, A.H., Thornhill, T.S.,
The capacity of cells to degrade type I collagen fibrils was assessed and Goldring, S.R. (1998). Identification of cell types responsible
as described (Havemose-Poulsen et al., 1998). Briefly, 24-well plates for bone resorption in rheumatoid arthritis and juvenile rheumatoid
were coated with a 1±2 mm film of reconstituted rat tail tendon type arthritis. Am. J. Pathol. 152, 943±951.
I collagen fibrils, and a pellet of 37,500 cells in 25 ml growth medium Havemose-Poulsen, A., Holmstrup, P., Stoltze, K., and Birkedal-
(DMEM, 10% [v/v] FBS) was seeded in the center of each well. Hansen, H. (1998). Dissolution of type I collagen fibrils by gingival
Newborn skin fibroblasts were allowed to attach for 5 hr, washed fibroblasts isolated from patients of various periodontitis categories.
3 times in HBSS, and then incubated for 5 days in serum free Opti- J. Periodontal Res. 33, 280±291.
MEM I (GIBCO-BRL, Gaithersburg, MD) with or without addition of Hiraoka, N., Allen, E., Apel, I.J., Gyetko, M.R., and Weiss, S.J. (1998).
1029 M IL-1b and 1028 M TNFa. Following incubation, cells were Matrix metalloproteinases regulate neovascularization by acting as
removed with trypsin/EDTA and the residual collagen fibril film pericellular fibrinolysins. Cell 95, 365±377.
stained with Coomassie blue.
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